SEC Comment Letter for Innoviva, Inc. (INVA) (CIK 0001080014) (INVA) — Jan 5, 2011

Innoviva, Inc. (INVA) (CIK 0001080014)
Date: Jan. 5, 2011 · CIK: 0001080014 · Accession: 0000000000-11-000754

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-30319

Date

January 5, 2011

Author

Not clearly detected

Form

UPLOAD

Company

Innoviva, Inc. (INVA) (CIK 0001080014)

Letter

January 5, 2011 Rick E Winningham Chief Executive Officer Theravance, Inc. 901 Gateway Blvd. South San Francisco, CA 94080

Re: Theravance, Inc. Form 10-K for the Fiscal Year Ended December 31, 2009 Filed February 26, 2010 Definitive Proxy Statement on Schedule 14A Filed March 24, 2010 File No. 000-30319

Dear Mr. Winningham: We have completed our review of your fili ngs and do not have any further comments at this time. Sincerely,

Jeffrey P. Riedler Assistant Director

Show Raw Text

January 5, 2011
 Rick E Winningham Chief Executive Officer Theravance, Inc. 901 Gateway Blvd.
South San Francisco, CA 94080

Re: Theravance, Inc.
 Form 10-K for the Fiscal Year Ended December 31, 2009
Filed February 26, 2010 Definitive Proxy Statement on Schedule 14A Filed March 24, 2010 File No. 000-30319

Dear Mr. Winningham:
We have completed our review of your fili ngs and do not have any further comments at
this time.
Sincerely,

Jeffrey P. Riedler Assistant Director

SecProbe.io